PLoS ONE (Jan 2022)

Strengthening Kangaroo Mother Care at a tertiary level hospital in Zambia: A prospective descriptive study.

  • Nobutu Muttau,
  • Martha Mwendafilumba,
  • Branishka Lewis,
  • Keilya Kasprzyk,
  • Colm Travers,
  • J Anitha Menon,
  • Kunda Mutesu-Kapembwa,
  • Aaron Mangangu,
  • Herbert Kapesa,
  • Albert Manasyan

DOI
https://doi.org/10.1371/journal.pone.0272444
Journal volume & issue
Vol. 17, no. 9
p. e0272444

Abstract

Read online

BackgroundGlobally, complications due to preterm birth are the leading contributor to neonatal mortality, resulting in an estimated one million deaths annually. Kangaroo Mother Care (KMC) has been endorsed by the World Health Organisation as a low cost, safe, and effective intervention in reducing morbidity and mortality among preterm infants. The objective of this study was to describe the implementation of a KMC model among preterm infants and its impact on neonatal outcomes at a tertiary level hospital in Lusaka, Zambia.MethodsWe conducted a prospective descriptive study using data collected from the KMC room at the University Teaching Hospital between January 2016 and September 2017. Mothers and government nurses were trained in KMC. We monitored skin-to-skin and breastfeeding practices, weight at admission, discharge, and length of admission.ResultsWe enrolled 573 neonates into the study. Thirteen extremely low weight infants admitted to the KMC room had graduated to Group A (1,000g-1,499g) at discharge, with a median weight gain of 500g. Of the 419 very low weight neonates at admission, 290 remained in Group A while 129 improved to Group B (1,500g-2,499g), with a median weight gain of 280g. Among the 89 low weight neonates, 1 regressed to Group A, 77 remained in Group B, and 11 improved to Group C (≥2,500g), individually gaining a median of 100g. Of the seven normal weight neonates, 6 remained in Group C individually gaining a median of 100g, and 1 regressed to Group B. Among all infants enrolled, two (0.35%) died in the KMC room.ConclusionsBased on the RE-AIM metrics, our results show that KMC is a feasible intervention that can improve neonatal outcomes among preterm infants in Zambia. The study findings show a promising, practical approach to scaling up KMC in Zambia.Trial registrationThe trial is registered under ClinicalTrials.gov under the following ID number: NCT03923023.